In this study, we used network pharmacology to predict the targets of SIN in treating DN, validated the therapeutic effect of SIN through molecular docking and animal experiments, and found that SIN exerts a renoprotective effect by inhibiting the production of NF-κB, which reduces the secretion of inflammatory factors. Here, NFKB1 is linked to liver dysplastic nodule.